Press

Fount Therapeutics, LLC is a sustainable drug discovery enterprise with a proven team of R & D talent that has created multiple launched medicines.

06.12.2018

Fount Therapeutics, LLC is a sustainable drug discovery enterprise with a proven team of R & D talent that has created multiple launched medicines. Fount is maturing three newco subsidiaries: Kinnate Biopharma, Inc. (Oncology), Immanate Therapeutics, Inc. (Immunology & Immuno-Oncology), and Audere Medicines, Inc. (theme undisclosed).